|
| Exchange Disseminated Time 17/10/2016 16:27:18 | Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on October 27, 2016, to consider and approve the Company's Unaudited Financial Statements for Second Quarter/Half Year ended September 30, 2016 (Q2).
Further, as per the "Code of Conduct for Prevention of Insider Trading" of the Company, the trading window closed for Directors and other designated employees of the Company on September 29, 2016 and will remain closed upto November 01, 2016 (both days inclusive) for the purpose of approval of Unaudited Financial Statements for the Second Quarter/Half Year ended September 30, 2016. |
|
|